[{"Assets_0_Q2_USD":51012054.0,"CommonStockSharesOutstanding_0_Q2_shares":62784480.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-4002579.0,"NetIncomeLoss_2_Q2_USD":-6182833.0,"NetIncomeLoss_1_Q2_USD":-4034035.0,"StockholdersEquity_0_Q2_USD":33544017.0,"Ticker":"VERU","CIK":"863894","name":"VERU INC.","OfficialName":"Veru Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1011836411.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190515"}]